Arcturus Therapeutics Holdings (ARCT) Other Working Capital Changes (2018 - 2026)
Arcturus Therapeutics Holdings (ARCT) posted Other Working Capital Changes of -$636000.0 for Q1 2026, up 96.93% on a QoQ basis from -$20.7 million in Q4 2025, and up 93.52% year-over-year from -$328645.8 in Q1 2025.
Arcturus Therapeutics Holdings (ARCT) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Arcturus Therapeutics Holdings' Other Working Capital Changes history runs 9 years deep, the most recent figure standing at -$636000.0 for Q1 2026.
- Quarterly Other Working Capital Changes rose 93.52% year-over-year to -$636000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.7 million (up 77.06% YoY) and the FY2025 annual result came in at -$23.9 million, up 56.76% from the prior year.
- Other Working Capital Changes was -$636000.0 for Q1 2026 at Arcturus Therapeutics Holdings, up from -$20.7 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.2 million in Q3 2023 and bottomed at -$4.5 million in Q1 2023.
- A 5-year average of -$55176.5 and a median of -$163000.0 in 2023 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes tumbled 2236.52% — and 2023, when it surged 2424.27%.
- Arcturus Therapeutics Holdings' Other Working Capital Changes stood at -$11.2 million in 2022, then soared by 141.41% to $4.6 million in 2023, then tumbled by 1231.1% to -$52.6 million in 2024, then soared by 60.54% to -$20.7 million in 2025, then soared by 96.93% to -$636000.0 in 2026.
- Business Quant data shows ARCT's Other Working Capital Changes at -$636000.0 in Q1 2026, -$20.7 million in Q4 2025, and $9.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arcturus Therapeutics Holdings | 164.57 Mn | -46.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -809,000.00 |
| Mar 31, 2026 | -809,000.00 |
| Mar 31, 2026 | -809,000.00 |
| Dec 31, 2025 | -916,000.00 |
| Dec 31, 2025 | -916,000.00 |
| Dec 31, 2025 | -916,000.00 |
| Sep 30, 2025 | 57,000.00 |
| Sep 30, 2025 | 57,000.00 |
| Sep 30, 2025 | 57,000.00 |
| Jun 30, 2025 | -2.94 Mn |
| Jun 30, 2025 | -2.94 Mn |
| Jun 30, 2025 | -2.94 Mn |
| Mar 31, 2025 | -1.20 Mn |
| Mar 31, 2025 | -1.20 Mn |
| Mar 31, 2025 | -1.20 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | 850,000.00 |
| Sep 30, 2024 | 850,000.00 |